162,116
Participants
Start Date
March 1, 2017
Primary Completion Date
March 1, 2017
Study Completion Date
March 1, 2017
oral antidiabetic drugs
OADs usage conditions and dose selection in T2DM patients
Medical Data Vision Co. Ltd, Shinagawa-ku
Lead Sponsor
Boehringer Ingelheim
INDUSTRY